AKT1 and cancer: Reportedly, the abrogation of metabolic activity triggered by the aberrant activation of the PI3K/AKT/mTOR pathway in cancer cells may result in the deregulation of genes involved in DNA damage and immune response, including DNA damage inducible transcript 4 (DDIT4).